JMPWA
CELGZ

JP Morgan Private Wealth Advisors’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio CELGZ Stock Details CELGZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-35,925
Closed -$42K – 1367
2016
Q1 		$42K Buy
+35,925
New +$48.1K ﹤0.01% 1200

Other funds holding CELGZ

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UAS
United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

JP Morgan Private Wealth Advisors's CELGZ Position: Q2 2016 in Review

JP Morgan Private Wealth Advisors sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q2 2016, closing a stake of 35,925 shares — an estimated $42K sold.

JP Morgan Private Wealth Advisors first reported a position in CELGZ in Q1 2016 and held it in 1 quarter. The position peaked at $42K in Q1 2016. 26 funds tracked by Wall St. Rank hold CELGZ as of Q2 2016.

  • JP Morgan Private Wealth Advisors reported no remaining Celgene Corporation Contingent Value Rights position as of Q2 2016 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 35,925 Celgene Corporation Contingent Value Rights shares in Q2 2016, an estimated $42K.
  • JP Morgan Private Wealth Advisors first reported a position in Celgene Corporation Contingent Value Rights in Q1 2016 and held it in 1 quarter.
  • JP Morgan Private Wealth Advisors's Celgene Corporation Contingent Value Rights position peaked at $42K in Q1 2016.
  • 26 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q2 2016.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.